Results 1 to 10 of about 19,232 (120)
Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine [PDF]
Archives of Razi Institute, 2021 Substance P binds to the Neurokinin-1 (NK-1) receptors found in the emetic center of the central nervous system (CNS) to induce emesis. Maropitant is a selective NK-1 receptor antagonist that inhibits the binding of substance P to NK-1 receptors and is ...
K Sharun +7 more
doaj +1 more source
Use of Coca-Cola drinks in gastric pathology in pediatric patients [PDF]
Romanian Journal of Pediatrics, 2020 Facing us the relatively frequent tendency of many people – medical professionals or not – to administer Coca-Colatype carbonated beverages in the case of nausea-type gastric symptoms or vomiting in pediatric or adult patients, we have tried to ...
Cristina Munteanu
doaj +1 more source
Utilizarea băuturilor de tip Coca-Cola în patologia gastrică la pacienţii pediatrici [PDF]
Romanian Journal of Pediatrics, 2020 În faţa tendinţei relativ frecvente a multor persoane – cadre medicale sau nu – de a administra băuturi carbogazoase de tipul Coca-Cola în cazul unor simptome gastrice de tip greaţă sau vărsături la pacienţii pediatrici sau adulţi, am încercat să ...
Cristina Munteanu
doaj +1 more source
Frontiers in Public Health, 2022 ObjectiveThe purpose of this study was to evaluate the cost-effectiveness and budget impact of fosaprepitant (FosAPR)-containing regimen for the prevention of chemotherapy-induced nausea and vomiting (CINV) among patients receiving high emetogenic ...
Xinglu Xu +7 more
doaj +1 more source
Comparative Study of Ondansetron and Palonosetron for Prevention of Nausea and Vomiting Following Upper Abdominal Surgeries under General Anaesthesia: A Randomised Control Trial [PDF]
Journal of Clinical and Diagnostic Research, 2020 Introduction: Postoperative Nausea and Vomiting (PONV) is a common entity following surgical procedure. It may result into serious complication like aspiration of gastric contents, prolonged recovery period.
Deepak Premnarayan Gupta, Vijay Chandak
doaj +1 more source
South Asian Journal of Cancer, 2020 Background Various predictive models have been developed which incorporates patient risk factors into the selection of optimal antiemetic therapy, one of which is chemotherapy-induced nausea and vomiting (CINV) risk scoring system developed by ...
Anita D’Souza +8 more
doaj +1 more source
Is PONV still a problem in pediatric surgery: a prospective study of what children tell us
Frontiers in Pediatrics, 2023 BackgroundPostoperative nausea and vomiting (PONV) is an unpleasant complication after surgery that commonly co-occurs with pain. Considering the high prevalence among pediatric patients, it is important to explore the main risk factors leading to PONV ...
Brigitte Messerer +8 more
doaj +1 more source
Treatment with Oral Ondansetron for Ultramarathon-Associated Nausea: The TOO FUN Study
Sports, 2021 Nausea and vomiting are common for runners during ultramarathons and often contribute to non-finishes. We aimed to determine the efficacy of ondansetron, a commonly used antiemetic, to treat nausea and vomiting in runners during an ultramarathon. Runners
Andrew V. Pasternak +4 more
doaj +1 more source
Plants, 2023 Quercetin (QUA), a flavonoid compound, is ubiquitously found in plants and has demonstrated a diverse range of biological activities. The primary objective of the current study is to assess the potential antiemetic properties of QUA using an in vivo and ...
Raihan Chowdhury +7 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Temsirolimus is a prodrug form of sirolimus (rapamycin). With its analogs (everolimus, ridaforolimus, and rapamycin), it forms a group of anticancer agents that block the activity of one of the two mammalian targets of rapamycin (mTOR) complexes, mTORC1.
Louiza Belkacemi +2 more
doaj +1 more source